CoChat

Tubeimoside I Antagonizes Yoda1-Evoked Piezo1 Channel Activation

Open access
Liu, Silin, Pan, Xianmei, Cheng, Wenbin, Deng, Bo, He, Yu, Zhang, Lei, Ning, Yile, Li, Jing · 2020 · Frontiers in Pharmacology
Cited by 50

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The mechanosensitive Piezo1 channels play roles in a wide range of biological processes, but its pharmacology is in its infancy. In this study, we sought to identify new Yoda1-dependent Piezo1 inhibitors. Intracellular Ca2+ measurements were made in HUVECs, HEK 293T cells overexpressing TRPC5 and TRPM2 channels, CHO K1 cells overexpressing TRPV4 channels, murine liver endothelial cells (MLECs), and macrophages. HEK 293T cells were transfected with a plasmid encoding GFP-tagged wild-type Piezo1. Isometric tension was recorded in mouse thoracic aorta rings. TBMS1 can strongly inhibit Yoda1 response, and its selectivity to Piezo1 channels was determined. The physiological responses of TBMS1 were identified by isometric tension, which can inhibit Yoda1 relaxation of aortic rings. Similarly, Yoda1-induced inhibitory results were obtained in Piezo1 wild-type overexpressed cells, MLECs, and macrophages. TBMS1 can effectively antagonize Yoda1 induced Piezo1 channel activation. This study sheds light on the existence of Yoda1 inhibitors and improves the understanding of vascular pharmacology through Piezo1 channels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2020.00768

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 50

Metadata

Authors
Liu, S., Pan, X., Cheng, W., Deng, B., He, Y., Zhang, L., Ning, Y., & Li, J.
Venue
Frontiers in Pharmacology
Published
2020-05-25
Volume
11
Pages
768-768
ISSN
1663-9812 (ISSN-L)
OpenAlex
W3027297319
Cited by
50
References
5
FWCI
1.65
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.